What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Cancer research, Molecular biology, Cancer cell, Response element and Retinoic acid.
His study in Cancer research is interdisciplinary in nature, drawing from both Cell culture, Carcinogenesis, Cancer, Estrogen receptor beta and Estrogen.
Harikrishna Nakshatri has researched Cancer cell in several fields, including Epithelial–mesenchymal transition, Metastasis, Stromal cell, Cancer stem cell and Myoepithelial cell.
His study on Retinoic acid also encompasses disciplines like
- Reporter gene which connect with Receptor,
- Transactivation and related Retinoid X receptor.
His Retinoid X receptor research is multidisciplinary, incorporating perspectives in Retinoid X receptor alpha, Nuclear protein and Retinoid X receptor beta.
His work deals with themes such as Thyroid hormone receptor, Retinoid X receptor gamma and Retinoid receptor, which intersect with Cell biology.
His most cited work include:
- Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently (1003 citations)
- Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently (1003 citations)
- Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α A NEW MODEL FOR ANTI-ESTROGEN RESISTANCE (829 citations)
What are the main themes of his work throughout his whole career to date?
Harikrishna Nakshatri mainly focuses on Cancer research, Breast cancer, Cancer, Internal medicine and Cancer cell.
His Cancer research research incorporates elements of Cell, Cancer stem cell, Estrogen receptor, Estrogen receptor alpha and Metastasis.
His studies deal with areas such as Tissue microarray, Gene, Bioinformatics and Pathology as well as Breast cancer.
His Cancer research integrates issues from Cell type, Pharmacology and Skeletal muscle.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology, microRNA and Oncology.
His research integrates issues of Molecular biology, Stromal cell, Signal transduction and Cytokine in his study of Cancer cell.
He most often published in these fields:
- Cancer research (57.55%)
- Breast cancer (34.89%)
- Cancer (31.65%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (57.55%)
- Breast cancer (34.89%)
- Cancer (31.65%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Breast cancer, Cancer, Cell and Gene.
His Cancer research study combines topics in areas such as CD44, Cancer cell, Estrogen receptor, Cell cycle and Cell type.
He has included themes like Carcinogenesis, Cancer stem cell and Doxorubicin in his Cancer cell study.
His biological study spans a wide range of topics, including Transcriptome, Metastasis, Tissue microarray and DNA methylation.
The concepts of his Cancer study are interwoven with issues in Progenitor cell and Immortalised cell line.
His research investigates the connection between Cell and topics such as Immune system that intersect with problems in GATA3.
Between 2017 and 2021, his most popular works were:
- An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations. (44 citations)
- Flower isoforms promote competitive growth in cancer (40 citations)
- Mutational landscape of RNA-binding proteins in human cancers. (34 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cancer research, Cancer, Breast cancer, Cell type and Cell culture.
His work carried out in the field of Cancer research brings together such families of science as CD44, Mammary tumor, Estrogen receptor alpha, Ovarian cancer and Epigenetics.
While the research belongs to areas of CD44, Harikrishna Nakshatri spends his time largely on the problem of Estrogen receptor, intersecting his research to questions surrounding Carcinogenesis, Cancer cell and Gene knockdown.
His research in Cancer intersects with topics in Death effector domain and Effector.
The study incorporates disciplines such as Type I collagen, Downregulation and upregulation, IκBα, Biochemistry and Cell biology in addition to Cell culture.
As part of one scientific family, Harikrishna Nakshatri deals mainly with the area of Cell biology, narrowing it down to issues related to the Gene isoform, and often Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
